Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share of Common Stock (Tables)

v3.24.1.1.u2
Loss Per Share of Common Stock (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
The following tables are a reconciliation of the numerators and denominators used in the calculation of basic and diluted net loss per share computations:
Three Months Ended
March 31, (Unaudited)
2024 2023
Basic EPS and diluted EPS:
Loss (Numerator)
Net loss $ (5,019,531) $ (5,167,520)
Shares (Denominator)
Weighted average common shares outstanding(1)
27,999,901  3,767,578 
Per-Share Amount $ (0.18) $ (1.37)
Schedule of anti-dilutive securities
The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been anti-dilutive:
Three Months Ended
March 31, (Unaudited)
2024
2023 (1)
Stock options 1,201,398  175,733 
Warrants 3,280,940  708,373 
Unvested restricted stock units
503,444  10,667 
Unvested restricted stock
5,000  — 
Convertible Debt
968,922  — 
___________________
(1) Previously reported outstanding shares of common stock equivalents were adjusted for the effects of the reverse stock split at a ratio of one-for-two hundred and fifty (1-for-250). The reverse stock split was transacted on September 6, 2023.